Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Cristina, Rovira"'
Autor:
Marc Argilés, Elisabet Fonts, Luis Pérez-Mañá, Beatriz Martinez-Navarro, Carles Sora-Domenjó, Elisabet Pérez-Cabré, Bernat Sunyer-Grau, Cristina Rovira-Gay, Carla Molins-Pitarch, Lluïsa Quevedo-Junyent
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Animated films are highly popular in society, particularly among children and adolescents. During film production, selecting an adequate colour palette and scene dynamism is crucial for creating a visual impact on the audience. However, the
Externí odkaz:
https://doaj.org/article/506bdf6efffd431aa3b0b1d25b8cf2ef
Autor:
Elisa de Lazzari, Daniel K. Nomah, Jose L. Blanco, Naira Rico, Xabier Filella, Natalia Egri, Raquel Ruiz, Maria Angeles Marcos, Maria del Mar Mosquera, Jose Alcamí, Sonsoles Sánchez-Palomino, Andreu Bruguera, Carmen Hurtado, Cristina Rovira, Juan Ambrosioni, Iván Chivite, Ana González-Cordón, Alexy Inciarte, Montserrat Laguno, María Martínez-Rebollar, Lorena de la Mora, Berta Torres, Yesika Díaz, Esteban Martínez, Josep Mallolas, Jose M. Miro
Publikováno v:
International Journal of Infectious Diseases, Vol 149, Iss , Pp 107266- (2024)
Objectives: The prevalence and risk factors of SARS-CoV-2 infection among unvaccinated people living with HIV (PWH) are not well understood, and the protective role of tenofovir remains controversial. This study aimed to assess the SARS-CoV-2 prevale
Externí odkaz:
https://doaj.org/article/9abffb66694149149fe8078163856415
Publikováno v:
Reports, Vol 7, Iss 2, p 22 (2024)
This case report provides us with insight on how blood glycemia affects refraction, vergence and accommodation in a single diabetic patient. A 21-year-old type I diabetic woman was the subject studied in this report. Refraction, near and far fusional
Externí odkaz:
https://doaj.org/article/909d261472e648298ee68181bc27e441
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0284552 (2023)
Two tests to measure fusional vergence amplitudes objectively were developed and validated against the two conventional clinical tests. Forty-nine adults participated in the study. Participants' negative (BI, base in) and positive (BO, base out) fusi
Externí odkaz:
https://doaj.org/article/e35a0b072cb449e9b64978013f7938dd
Autor:
Lorna Leal, Elvira Couto, Sonsoles Sánchez-Palomino, Núria Climent, Irene Fernández, Laia Miralles, Yolanda Romero, Tania González, Maria José Maleno, Blanca Paño, Judit Pich, Carlos Nicolau, José Maria Gatell, Montserrat Plana, Felipe García, the DCV3-RISVAC04 Study Group, Carmen Hurtado, Laura Burunat, Joan Albert Arnaiz, Rafael Salvador, Elisabet Farré, Berta Torres, Constanza Lucero, Montserrat Laguno, María Martínez-Rebollar, Ana González-Cordón, John Rojas, Alexy Inciarte, Lorena de la Mora, Josep Mallolas, Esteban Martínez, José Luis Blanco, Unai Perpiñá, Josep Canals, Raquel Martín, Florencia Echeverry, Cristina Xufré, Cristina Rovira, Marta Sala, Amparo Tricas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionFunctional cure has been proposed as an alternative to lifelong antiretroviral therapy and therapeutic vaccines represent one of the most promising approaches.Materials and MethodsWe conducted a double-blind randomized placebo-controlled
Externí odkaz:
https://doaj.org/article/a8aaf114260f4143b36d72f882f69ca3
Autor:
Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, Pep Coll, Sara Morón-López, Maria C. Puertas, Miriam Rosas-Umbert, Patricia Cobarsi, Roser Escrig, Núria Perez-Alvarez, Irene Ruiz, Cristina Rovira, Michael Meulbroek, Alison Crook, Nicola Borthwick, Edmund G. Wee, Hongbing Yang, Jose M. Miró, Lucy Dorrell, Bonaventura Clotet, Javier Martinez-Picado, Christian Brander, Tomáš Hanke
Publikováno v:
EClinicalMedicine, Vol 11, Iss , Pp 65-80 (2019)
Background: Strong and broad antiviral T-cell responses targeting vulnerable sites of HIV-1 will likely be a critical component for any effective cure strategy. Methods: BCN01 trial was a phase I, open-label, non-randomized, multicenter study in HIV-
Externí odkaz:
https://doaj.org/article/9525071b69b242ee8ae52281b8baa3b5
Autor:
Lorna Leal, Alberto C. Guardo, Luis M. Bedoya, Cristina Rodríguez de Miguel, Núria Climent, Cristina Rovira, Manuela Beltrán, Josep Llach, Jose Alcamí, Angela D.M. Kashuba, Jose M. Gatell, Montserrat Plana, Felipe García
Publikováno v:
AIDS Research and Human Retroviruses. 39:211-221
Autor:
Núria Climent, Juan Ambrosioni, Tània González, Cristina Xufré, Maria Casadellà, Marc Noguera-Julian, Roger Paredes, Montserrat Plana, Judith Grau-Expósito, Josep Mallolas, José Alcamí, Sonsoles Sánchez-Palomino, José M Miró, David Nicolás, Carmen Hurtado, Cristina Rovira, Omar Sued, Mercé Brunet, María López-Diéguez, Christian Manzardo, Fernando Agüero, Montserrat Tuset, Alberto C Guardo, Maria A. Marcos, María del Mar Mosquera, M. Ángeles Muñoz-Fernández, Miguel Caballero, Carmen Ligero, Emma Fernández, M. Ángeles Marcos, José M Gatell, Elisa de Lazzari, Teresa Gallart, Ana Fernandez-Tenreiro, Begoña Gomez, Leire Berrocal
Publikováno v:
The Lancet HIV. 10:e42-e51
Although antiretroviral therapy (ART) is effective in suppressing viral replication, HIV-1 persists in reservoirs and rebounds after ART has been stopped. However, a very few people (eg, elite and post-treatment controllers) are able to maintain vira
Autor:
Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, Christian Manzardo, Maria C. Puertas, Sara Morón-López, Anuska Llano, Cristina Miranda, Samandhy Cedeño, Miriam López, Yovaninna Alarcón-Soto, Guadalupe Gómez Melis, Klaus Langohr, Ana M. Barriocanal, Jessica Toro, Irene Ruiz, Cristina Rovira, Antonio Carrillo, Michael Meulbroek, Alison Crook, Edmund G. Wee, Jose M. Miró, Bonaventura Clotet, Marta Valle, Javier Martinez-Picado, Tomáš Hanke, Christian Brander, José Moltó, The BCN02 Study Investigators
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Kick&kill strategies combining drugs aiming to reactivate the viral reservoir with therapeutic vaccines to induce effective cytotoxic immune responses hold potential to achieve a functional cure for HIV-1 infection. Here, we report on an open-label,
Externí odkaz:
https://doaj.org/article/488e5500178f4b47bb1f5b03a865f708
Autor:
Miriam Rosás-Umbert, Marta Ruiz-Riol, Marco A. Fernández, Marta Marszalek, Pep Coll, Christian Manzardo, Samandhy Cedeño, José M. Miró, Bonaventura Clotet, Tomáš Hanke, José Moltó, Beatriz Mothe, Christian Brander, the BCN02 study group, Susana Benet, Anuksa Llano, Javier Martinez-Picado, Sara Morón-López, Roger Paredes, Maria C. Puertas, Roser Escrig, Silvia Gel, Miriam López, Cristina Miranda, Jose Muñoz, Nuria Perez-Alvarez, Jordi Puig, Boris Revollo, Jessica Toro, Ana Maria Barriocanal, Magi Farré, Cristina Perez-Reche, Marta Valle, Juan Ambrosioni, Irene Ruiz, Cristina Rovira, Carmen Ligero, Jose M. Miro, Antonio Carrillo, Michael Meulbroek, Ferran Pujol, Jorge Saz, Nicola Borthwick, Alison Crook, Edmund G. Wee
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Romidepsin (RMD) is a well-characterized histone deacetylase inhibitor approved for the treatment of cutaneous T-cell lymphoma. in vitro and in vivo studies have demonstrated that it is able to induce HIV-1 gene expression in latently infected CD4+ T
Externí odkaz:
https://doaj.org/article/7ff34c69a231482fa4c4bba2e9a493f3